
BASINGSTOKE, England, Feb. 22 (UPI) -- Shire said Thursday it launched Fosrenol in the United Kingdom for the treatment of patients with chronic kidney disease.
The drug is approved in the United Kingdom for controlling hyperphosphatemia in patients on hemodialysis or continuous ambulatory peritoneal dialysis.
"Shire is delighted to launch Fosrenol in the UK where effective control of serum phosphate levels is seen as complex and challenging for patients with CKD, many of whom have to take numerous tablets with each meal to control their phosphate," said John Freeman, Shire's managing director.
"Fosrenol provides a new treatment option for patients helping them simplify their management of hyperphosphatemia," Freeman added.
Shire estimates that approximately 70 percent of the 23,000 patients in the United Kingdom with end-stage renal disease suffer from hyperphosphatemia. Most of these could keep their phosphate levels under control with one Fosrenol tablet at each meal, the company said.
|
|
|
|
|
|
| Additional Health News Stories | |
MIAMI, May 27 (UPI) --
Tropical Storm Beryl neared hurricane strength ahead of its expected landfall Sunday night on the Southeast Coast of the United States, U.S. forecasters said.
|
'Men in Black' leads U.S. box office ... Michelle Obama, daughters see Beyonce ... Lady Gaga cancels Jakarta gig for security ... Madonna asks for pool at Israel venue ... News from United Press International.
|
ANCHORAGE, Alaska, May 27 (UPI) --
A black bear didn't go over a river but went to the woods after scampering through residential and industrial areas of Anchorage, Alaska, police said.
|
To avoid a meltdown in 2006, Ford Motor Co. mortgaged the farm putting up its assets – including its Blue Oval logo, and F-150 pickup and iconic Mustang trademarks – to secure $23.5 billion in credit.
|
| Stories | Photos | People | Comments |
View Caption